Akoya biosciences names bostongene as a qualified cro service provider

Waltham, mass.--(business wire)--bostongene, a leading provider of ai-driven molecular and immune profiling solutions, announced today that it has been named as a qualified contract research organization (cro) of akoya biosciences (nasdaq: akya; “akoya”). by combining akoya's single-cell imaging solutions with bostongene's unparalleled expertise in spatial proteomics sample processing and analysis, researchers will gain unprecedented access to the intricate landscape of cellular biology, paving.
AKYA Ratings Summary
AKYA Quant Ranking